Research Article
Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer
Figure 1
Overall survival for the entire study cohort. The Kaplan–Meier survival analysis for entire study cohort showed that ACT had better OS than non-ACT (HR = 0.800, CI: (0.751–0.851), ). ACT: adjuvant chemotherapy; OS: overall survival; and non-ACT: nonadjuvant chemotherapy.